Wayne State University

Aim Higher

Policies and the Human Research Protection Program Manual

The Human Research Protection Program Manual

Section 1 Wayne State University Human Research Policy

1-2 Wayne State University Human Research Protection Program

1-3 Wayne State University Human Protection Program: Roles and Responsibilities

1-4 What is Human Participant Research?

Section 2 Ethical Principles

2-1 Belmont Report

2-2 Nuremberg Code

2-3 Declaration of Helsinki

Section 3 WSU Affiliate Contracts and Agreements

3-3 John D. Dingell Veterans Administration Medical Center Memo of Understanding

Institutional Review Board Policies and Procedures

Section 4 Protocol Review

4-1 Types of IRB Reviews

4-2 Initial Protocol Submission Requirements

4-3 Unexpected Problems (Also refer to Section 13)

4-4 Exempt Review Procedures

4-5 Expedited Review Procedures

4-6 Amendments to the Research Protocols and Informed Consent (03/2012)

4-7 Continuation/Renewal of Protocol

4-8 Closure of a Research Protocol (03/2013)

4-9 Determining Projects that Require Additional Verification

4-10 Criteria for Determining Frequency of Review (02/2012)

4-11 Outcomes of Proposal Reviews by the Institutional Review Board

4-12 Notification of IRB Decisions to Principal Investigator and PI Response

4-13 Conditional Approvals and Subsequent Decisions by IRB Chairs

4-14 General Counsel: Roles and Responsibilities

4-15 Document Retention for Research Protocols

4-16 Quality Improvement Program

4-17 CIRB Policy

Section 5 Institutional Review Board

5-1 Expectations of IRB Membership

5-2 Selection and Review of Institutional Review Board Members and Staff

5-3 Policy and Procedure Development and Approval

5-4 Selection of Alternative IRB Member for Duly Constituted Meeting (02/2012)

5-5 Minutes Requirements (07/2012)

Section 6 Principal Investigator

6-1 Principal Investigator: Roles and Responsibilities

6-2 Investigator Initiated Research

6-3 Collaborating Research

6-4 International Research

6-5 State and Local Statutes

6-6 Department of Defense Requirements for Human Subject Research Protection

Section 7 Recruitment and Participant Rights

7-1 Recruitment of Research Participants

7-2 The Inclusion of Pregnant Women in Research

7-3 The Inclusion of Women and Minorities in Research

7-4 Advertising

7-5 Finders Fee

7-6 Costs Associated with Research Participation

7-7 Compensation for Research Participation

Section 8 Research Involving Vulnerable Participants

8-1 Research Involving Fetuses and Neonates

8-2 Vulnerable Participants: Children (07/2012)

8-3 Vulnerable Participants: Cognitively Impaired and Mentally Disabled

8-4 Vulnerable Participants: Prisoners

8-5 Vulnerable Participants: Terminally Ill

8-6 Vulnerable Participants: Normal Volunteers

8-7 Vulnerable Participants: Students, Trainees and Employees

Section 9 Informed Consent

9-1 Informed Consent Options

9-2 Informed Consent Involving Non-English Speaking Participants

9-3 Informed Consent Process

9-4 Obtaining Permission from Legally Authorized Representatives or Family Members

Section 10 HIPAA

10-1 HIPAA Requirements in Research

10-2 HIPAA Flowcharts

10-3 HIPAA Tip Sheet

Section 11 Research Involving Drugs and Devices

11-1 Investigational Drug Research

11-2 Approved and Unapproved Devices in Research

11-3 Emergency Single Time Use of a Test Article (Drug, Biologic, Device)

11-4 Humanitarian Use Device

11-5 Off Label Use of Drugs and Devices

11-6 Planned Emergency Research

11-7 Compassionate and Expanded Use of Drugs and Devices

Section 12 Research Procedures

12-1 The Use of Biological Specimens in Research

12-2 Data Safety and Monitoring in Research

12-3 Research Studies Involving the Collection of Blood Samples

Section 13 Reporting Responsibility

13-1 Unexpected Problems (04/2013)

13-2 Reporting Unexpected Problems

13-3 Adverse Event Algorithm

13-4 Determining which Adverse Events are Unexpected

Section 14 Conflict of Interest

14-1 Conflict of Interest: Principal Investigator/Key Personnel

14-2 Conflict of Interest: Institutional Review Board Members and IRB Administration Staff

Section 15 Non-Compliance

15-1 Identifying, Defining and Managing Non-Compliance in Human Research

15-2 For Cause Audits

15-3 Suspension and Termination of Research Protocols

Section 16 References

16-1 Glossary

16-2 FDA

16-3 OHRP

16-4 Dingell Veterans Administration Policy

16-5 Good Clinical Practice

16-6 FDA Guidance

16-7 FDA Devices

16-8 Department of Defense (DoD)

16-9 Department of Energy (DoE)

16-10 Department of Education

16-11 Environmental Protection Agency (EPA)

 

Contact Information

IRB Administration Office
87 E. Canfield, Second Floor
Detroit , MI 48201
(313) 577-1628


Associate Director of IRB Administration (313) 993-7155
Education Coordinator (313) 577-9534


Division of Research, Office of Research Compliance (313) 577-9064